FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Galenica

New management at Vifor Pharma and new Galenica Group CFO designated

07-Oct-2016 - The Board of Directors of the Galenica Group has designated Stefan Schulze, currently CEO of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), as Chief Operating Officer (COO) and President of the Executive Committee of Vifor Pharma. Under the proven leadership of the Executive Chairman of the ...

appointments personnel changes

BioGaia signs agreement with Moroccan pharmaceutical company Galenica SA for Morocco

05-Aug-2011 - The agreement with Galenica gives the company exclusive rights to distribute BioGaia's Probiotic drops and tablets under the BioGaia brand in Morocco. The launch is planned for the first quarter of 2012."We are pleased that the agreement has given us access to an interesting new region with ...

Morocco

CellCept reaches positive results in Phase III trial in Lupus Nephritis

07-Jun-2010 - Vifor Pharma, the pharma business sector of the Galenica Group, and Roche announced that the maintenance phase of the Aspreva Lupus Management Study (ALMS) has successfully achieved its primary endpoint. The trial demonstrates the superiority of Roche’s CellCept (mycophenolate mofetil) versus ...

cyclophosphamide medicine nephritis +4

Aspreva's plan of arrangement with Galenica completed

07-Jan-2008 - Aspreva Pharmaceuticals Corporation announced the completion of the plan of arrangement with Galenica Group, pursuant to which Galenica, through a wholly-owned Canadian subsidiary, acquired all outstanding shares of Aspreva for US$26.00 per share in cash. With the completion of the plan of ...